We report a meta-analysis of randomised, controlled, clinical trials of systemic anti-fibrinolytics in traumatic hyphaema . Outcome measures were rate of secondary haemorrhage and final visual acuity. An estimate of the overall odds ratio for each outcome measure was calcu lated both by combining the logarithms of the odds ratios, and by the Mantel-Haenszel method. The results confirm a beneficial effect of systemic antifibrinolytics on the rate of secondary haemorrhage, but not on final visual acuity.
Meta-analysis is a method of formal statistical analysis of data from several published trials, and may be con sidered to be a more rigorous alternative to narrative liter ature review. It has been widely applied in the social sciences, psychology and medicine, for example to resolve doubts about the role of intravenous streptokinase The following data were extracted from each trial report: The number of patients in both treatment and con trol groups with (1) secondary haemorrhage, (2) Tables I to III give the raw data used in the 2 x 2 tables for the three outcome measures: rate of secondary haemor rhage, final visual acuity 6/18 or worse, and final visual acuity 6/60 or worse.
RESULTS
The studies used in each meta-analysis and the results 
DISCUSSION
The results of our meta-analysis confirm that systemic anti-fibrinolytics reduce the rate of secondary haemor rhage in patients with traumatic hyphaema. A treatment effect was found by four of the published trials used in the meta-analysis,9-11.13 the remaining two finding no differ ence between the treated and untreated group.12.14 This illustrates the power of meta-analysis to resolve contro versy in a scientific manner. The visual benefit of a reduc tion in the rate of secondary haemorrhage, however, is not clear from this study. No significant difference in final visual outcome could be detected between the treatment and control groups, suggesting that a secondary haemor rhage, as defined in the published trials, is not necessarily published trials, is prone to publication bias. There is evi dence that a trial with a significant treatment effect is more likely to be published in a medical journal than one with non-significant results.21
The clinical decision of whether to use anti-fibrinolytics in the management of traumatic hyphaema is a multifac torial one. The severity of the hyphaema, the age and con dition of the patient, the possible side-effects and the cost of treatment all contribute to the decision, as well as the likelihood of a beneficial treatment effect. Our meta analysis suggests that although anti-fibrinolytics will reduce the chance of a secondary haemorrhage occurring, the benefit of doing so is unclear.
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